COLLEGIUM PHARMACEUTICAL, INC Business Finance Contracts & Agreements
39 Contracts & Agreements
- Indenture Agreements (3 contracts)
- Investor Rights Agreements (1)
- Loan Agreements (13)
- Note Agreements (2)
- Purchase Agreements (1)
- Shareholders Agreements (1)
- Stock Agreements (8)
- Subordination Agreement (2)
- Underwriting Agreements (4)
- Warrant Agreements (4)
- Third Amendment to Loan Agreement, dated as of June 23, 2023, by and among Collegium Pharmaceutical, Inc., the guarantors party thereto, BioPharma Credit PLC, and Bio Pharma... (Filed With SEC on August 3, 2023)
- Second Amendment to Loan Agreement, dated as of February 6, 2023, Amended and Restated Loan Agreement, dated as of March 22, 2022, by and among Collegium Pharmaceutical, Inc., the... (Filed With SEC on February 23, 2023)
- Indenture, dated as of February 10, 2023, between Collegium Pharmaceutical, Inc. and The Bank of New York Mellon Trust Company, N.A., as trustee (Filed With SEC on February 13, 2023)
- Second Amendment to Loan Agreement, dated as of May 27, 2020, by and among the Company, Collegium Securities Corporation, BioPharma Credit PLC, as collateral agent, BPCR Limited... (Filed With SEC on August 5, 2020)
- First Amendment to Loan Agreement, dated as of February 24, 2020, by and among the Company, its subsidiaries, BioPharma Credit PLC, as collateral agent and lender, and BioPharma... (Filed With SEC on May 7, 2020)
- First Supplemental Indenture, dated as of February 13, 2020, between Collegium Pharmaceutical, Inc. and The Bank of New York Mellon Trust Company, N.A., as trustee (Filed With SEC on February 13, 2020)
- Indenture, dated as of February 13, 2020, between Collegium Pharmaceutical, Inc. and The Bank of New York Mellon Trust Company, N.A., as trustee (Filed With SEC on February 13, 2020)
- Underwriting Agreement, dated as of February 10, 2020, between Collegium Pharmaceutical, Inc. and Jefferies LLC (Filed With SEC on February 13, 2020)
- Loan Agreement, dated as of February 6, 2020, by and among the Company, its subsidiaries, BioPharma Credit PLC, as collateral agent and lender, and BioPharma Credit Investments V... (Filed With SEC on February 10, 2020)
- Purchase Agreement, dated as of February 6, 2020, by and between Collegium Pharmaceutical, Inc. and Assertio Therapeutics, Inc (Filed With SEC on February 10, 2020)
- Warrant, issued November 8, 2018 (Filed With SEC on November 8, 2018)
- Amended and Restated Loan and Security Agreement, dated November 1, 2018, by and between Silicon Valley Bank and Collegium Pharmaceutical, Inc (Filed With SEC on November 8, 2018)
- Seventh Amendment to Loan and Security Agreement, dated March 30, 2018, by and between Silicon Valley Bank and Collegium Pharmaceutical, Inc (Filed With SEC on May 9, 2018)
- Consent and Sixth Amendment to Loan and Security Agreement, dated January 9, 2018, by and between Collegium Pharmaceutical, Inc. and Silicon Valley Bank (Filed With SEC on January 10, 2018)
- Collegium Pharmaceutical, Inc. Shares of Common Stock (par value $0.001 per share) Controlled Equity OfferingSM Sales Agreement (Filed With SEC on March 13, 2017)
- 5,000,000 Shares Collegium Pharmaceutical, Inc. UNDERWRITING AGREEMENT (Filed With SEC on October 27, 2016)
- [ ] Collegium Pharmaceutical, Inc. UNDERWRITING AGREEMENT (Filed With SEC on January 4, 2016)
- COLLEGIUM PHARMACEUTICAL, INC. Restricted Stock Award Agreement (Filed With SEC on April 27, 2015)
- COLLEGIUM PHARMACEUTICAL, INC. 2015 EMPLOYEE STOCK PURCHASE PLAN (Filed With SEC on April 27, 2015)
- [ ] Collegium Pharmaceutical, Inc. UNDERWRITING AGREEMENT(1) (Filed With SEC on April 27, 2015)
- COLLEGIUM PHARMACEUTICAL, INC. Series D Convertible Preferred Stock Purchase Agreement Dated as of March 6, 2015 (Filed With SEC on April 2, 2015)
- COLLEGIUM PHARMACEUTICAL, INC. NON-STATUTORY STOCK OPTION AGREEMENT (Filed With SEC on April 2, 2015)
- SUBORDINATION AGREEMENT (Filed With SEC on April 2, 2015)
- SUBORDINATION AGREEMENT (Filed With SEC on April 2, 2015)
- CONVERTIBLE NOTE PURCHASE AGREEMENT (Filed With SEC on April 2, 2015)
- AMENDMENT NO. 1 TO SERIES C CONVERTIBLE PREFERRED STOCK PURCHASE AGREEMENT (Filed With SEC on April 2, 2015)
- COLLEGIUM PHARMACEUTICAL, INC. Series C Convertible Preferred Stock Purchase Agreement Dated as of August 27, 2013 (Filed With SEC on April 2, 2015)
- COLLEGIUM PHARMACEUTICAL, INC. Series B Convertible Preferred Stock Purchase Agreement Dated as of February10, 2012 (Filed With SEC on April 2, 2015)
- FOURTH AMENDMENT TO LOAN AND SECURITY AGREEMENT (Filed With SEC on April 2, 2015)
- THIRD AMENDMENT TO LOAN AND SECURITY AGREEMENT (Filed With SEC on April 2, 2015)
- ASSUMPTION AND SECOND AMENDMENT TO LOAN AND SECURITY AGREEMENT (Filed With SEC on April 2, 2015)
- FIRST AMENDMENT TO LOAN AND SECURITY AGREEMENT (Filed With SEC on April 2, 2015)
- LOAN AND SECURITY AGREEMENT (Filed With SEC on April 2, 2015)
- WARRANT TO PURCHASE STOCK (Filed With SEC on April 2, 2015)
- WARRANT TO PURCHASE STOCK (Filed With SEC on April 2, 2015)
- WARRANT TO PURCHASE STOCK (Filed With SEC on April 2, 2015)
- PREFERRED SHAREHOLDER AGREEMENT (Filed With SEC on April 2, 2015)
- COLLEGIUM PHARMACEUTICAL, INC. EIGHTH AMENDED AND RESTATED INVESTOR RIGHTS AGREEMENT (Filed With SEC on April 2, 2015)
- CONVERTIBLE PROMISSORY NOTE (Filed With SEC on April 2, 2015)
